Percutaneous Valve Repair and Replacement: Challenges Encountered, Challenges Met, Challenges Ahead

This issue of Circulation contains reports on the acute results of 2 approaches for percutaneous heart valve treatment.1,2 The introduction of nonsurgical, catheter-based approaches to the management of valvular heart disease is in a phase of rapid development. These 2 reports highlight both challenges and successes in phase I experience with these innovative therapies. Articles pp 842 and 851 Percutaneous valve therapy developed initially with aortic valve replacement, described by Andersen et al3 in 1992 in a swine model. These investigators fabricated a stent-mounted bioprosthetic valve and demonstrated that percutaneous implantation is feasible. Bonhoeffer et al4 reported the use of a stent-mounted bioprosthesis for pulmonic valve replacement in 2000. This achievement clearly marked the beginning of the era of percutaneous valve replacement therapy in patients. Pulmonic valve replacement with this percutaneous approach has been remarkably successful. To date, >100 patients have been treated, with only a single procedure-related mortality and good results in a population of pediatric patients with congenital heart disease who otherwise would face third or fourth open heart procedures. Percutaneous aortic valve replacement with a stent-mounted bioprosthetic valve device was initially reported by Cribier et al5,6 in 2002, with a growing experience since then. Numerous technical and clinical challenges have been encountered during phase I procedures for percutaneous heart valve therapy. The patient population for aortic valve replacement has been a group of patients considered high risk for surgery or nonsurgical candidates with numerous comorbid conditions. These patients have come to the cardiac catheterization laboratory with hypotension and low cardiac output. Under the best circumstances, they represent a great management challenge, even without the demands of new, complex percutaneous procedures. Early mortality in this group has been high, but there have also been stunning successes. Percutaneous aortic valve replacement was initially accomplished by …

[1]  Christopher E. Buller,et al.  Percutaneous Aortic Valve Implantation Retrograde From the Femoral Artery , 2006, Circulation.

[2]  J. Harnek,et al.  Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With Device Implantation in the Coronary Sinus , 2006, Circulation.

[3]  J M Hasenkam,et al.  Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. , 1992, European heart journal.

[4]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[5]  Thomas A Vassiliades,et al.  The clinical development of percutaneous heart valve technology. , 2005, The Journal of thoracic and cardiovascular surgery.

[6]  Allan Schwartz,et al.  Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.

[7]  Assaf Bash,et al.  Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. , 2004, Journal of the American College of Cardiology.

[8]  W. Edwards,et al.  Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. , 2004, Journal of the American College of Cardiology.

[9]  P. Bonhoeffer,et al.  Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction , 2000, The Lancet.

[10]  R. Levine,et al.  American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography , 2003 .

[11]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  Thomas Felderhoff,et al.  First report on a human percutaneous transluminal implantation of a self‐expanding valve prosthesis for interventional treatment of aortic valve stenosis , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.